YFY Biotech Management Company

TaiMed Biologics Inc. operates as a biotechnology company. The company develops Ibalizumab, a monoclonal Antibody (mAb) and a member of HIV viral-entry inhibitor therapy. TaiMed Biologics Inc. was founded in 2007 and is based in Taipei, Taiwan.

TaiGen Biotechnology Co., Ltd. is a pharmaceutical company headquartered in Taipei, Taiwan, with additional operations in Beijing, China, and the United States. Founded in 2001, the company specializes in the discovery, development, and commercialization of innovative therapeutics aimed at treating cancers, infectious diseases, and diabetic complications. Its product portfolio includes Nemonoxacina, an anti-infection drug effective against various forms of pneumonia and skin infections; Taigexyn, a non-fluorinated quinolone antibiotic; and TG-1000, which treats influenza A and B. Additionally, TaiGen develops stem cell mobilizers for enhancing the circulation of stem and progenitor cells and offers treatments for hepatitis C, anti-influenza drugs, and antibiotics targeting gram-negative bacteria.

Nereus Pharmaceuticals, Inc. engages in the discovery and development of therapeutics for the treatment of oncology, infectious diseases, and inflammation. The company uses its marine microbiology technologies for the discovery and development of drug candidates. Its oncology drug candidates include NPI-2358, a tumor vascular disrupting agent for the treatment of solid tumors; and NPI-0052, a proteasome inhibitor for the treatment of solid tumors, lymphomas, and multiple myeloma. The company was founded in 1998 and is based in San Diego, California.

SunTen Phytotech Co., Ltd. is an herbal-based biotechnology company focused on developing botanical medicines and functional dietary products. The company offers a range of products designed to address various medical needs. These include SB221, a blend of traditional Chinese herbal extracts aimed at treating and preventing vascular endothelial dysfunction-related diseases; STA36, which serves as a botanical composition for the adjuvant treatment of chronic asthma; STD052, a partially purified herbal material targeting gastrointestinal, cardiovascular, and kidney diseases; and STD06, an active component formulated for skin disorders and wound healing. SunTen Phytotech is dedicated to providing access to herbal remedies that promote healing and overall health.

Elixir Pharmaceuticals is a pharmaceutical company focused on the discovery, development and commercialization of novel pharmaceuticals for the treatment of metabolic diseases such as diabetes and obesity. The Company's scientific founders identified that interactions between specific genes and enzymes can slow the aging process, and they are developing compounds that stimulate these interactions and will be used to treat a range of diseases of aging, including metabolic disease.

Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on discovering, developing and commercializing anti-infective products. It has two late-stage anti-infective product candidates, fidaxomicin and Pruvel (prulifloxacin). Optimer's development efforts are focused on products that treat gastrointestinal infections, and related diseases where therapies have limitations. Its product portfolio includes Fidaxomicin, Pruvel, CEM-101, OPT-822/OPT-821 Combination Therapy and OPT-88.